Reaction
Human Herpesvirus 8 Infection reporting signals
As of the last recalculation, Human Herpesvirus 8 Infection appears in 600 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 196.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 60 | 196.5 | 197.5 |
| Tacrolimus Ointment 0.1% | 315 | 183.6 | 184.1 |
| Tacrolimus Extended-Release Capsules | 315 | 183.1 | 183.6 |
| Tacrolimus | 323 | 153.8 | 154.1 |
| Ganciclovir | 34 | 122.1 | 122.5 |
| Ganciclovir Sodium | 34 | 118.1 | 118.5 |
| Sirolimus | 42 | 116.2 | 116.6 |
| Mycophenolate Mofetil | 222 | 89.4 | 89.6 |
| Mycophenolate Mofetil Hydrochloride | 222 | 89.3 | 89.4 |
| Everolimus Tablets | 31 | 67.6 | 67.7 |
| Valganciclovir Hydrochloride Powder, | 21 | 61.9 | 62.0 |
| Atovaquone | 11 | 48.3 | 48.3 |
| Valganciclovir | 23 | 44.0 | 44.0 |
| Valganciclovir Hydrochloride | 23 | 44.0 | 44.0 |
| Melphalan | 25 | 39.7 | 39.8 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 39.3 | 39.3 |
| Mycophenilic Acid | 22 | 38.2 | 38.2 |
| Melphalan Hydrochloride | 25 | 36.1 | 36.1 |
| Clobetasol Propionate Ointment Usp, 0.05% | 10 | 34.2 | 34.3 |
| Clobetasol Propionate | 10 | 34.1 | 34.1 |
| Mycophenolic Acid | 22 | 24.7 | 24.7 |
| Everolimus | 31 | 22.2 | 22.2 |
| Ifosfamide | 13 | 21.4 | 21.4 |
| Remdesivir | 8 | 21.1 | 21.1 |
| Busulfan | 9 | 20.1 | 20.1 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 16.2 | 16.2 |